The prevalence of and risk factors for barrett's esophagus in a Korean population: A nationwide multicenter prospective study

Journal of Clinical Gastroenterology

Volumn 43, Issue 10, 2009, Pages 907-914

  Park, Jong Jae ^a   Kim, Jae Woo ^a   Kim, Hyun Jin ^a   Chung, Moon Gi ^b   Park, Seon Mee ^c   Baik, Gwang Ho ^d   Nah, Byung Kyu ^e   Nam, Su Youn ^f   Seo, Kang Seok ^g   Ko, Byung Sung ^h   Jang, Jae Young ^j   Kim, Byeong Gwan ^k   Kim, Ji Won ^k   Choi, Youn Seon ⁱ   Joo, Moon Kyung ^a   Kim, Jin Il ^l   Cho, Mee Yon ⁿ   Kim, Nayoung ^m,o   Park, Soo Heon ^l   Jung, Hyun Chae ^m   Chung, In Sik ^l   more..

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Hallym University College of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f National Cancer Center   (South Korea)

^g Gwangju Christian Hospital   (South Korea)

^h Eulji University   (South Korea)

ⁱ Korea University College of Medicine   (South Korea)

^j Kyung Hee University Hospital   (South Korea)

^k Seoul National University Boramae Hospital   (South Korea)

^l The Catholic University of Korea College of Medicine   (South Korea)

^m Seoul National University College of Medicine   (South Korea)

ⁿ Departments of WInternal Medicine

^o Yonsei University Wonju College of Medicine   (South Korea)

more..

Author keywords

Barrett esophagus, prevalence, reflux symptom, risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; COMORBIDITY; CONTROLLED STUDY; DRUG USE; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; ETHNIC GROUP; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HIATUS HERNIA; HUMAN; HYPERTENSION; KOREA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; SEX DIFFERENCE; AGE; CLINICAL TRIAL; DIGESTIVE TRACT ENDOSCOPY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; REFLUX ESOPHAGITIS; THORAX PAIN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BARRETT ESOPHAGUS; CHEST PAIN; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGITIS, PEPTIC; FEMALE; HERNIA, HIATAL; HUMANS; KOREA; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 74949128886     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318196bd11     Document Type: Article

References (53)

1. Hirota WK, Loughney TM, Lazas DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology. 1999;116:277-285.
2. Pera M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res. 2000;155:1-14.
3. Kim JH, Rhee PL, Lee JH, et al. Prevalence and risk factors of Barrett's esophagus in Korea. J Gastroenterol Hepatol. 2007; 22:908-912.
4. Kim JY, Kim YS, Jung MK, et al. Prevalence of Barrett's esophagus in Korea. J Gastroenterol Hepatol. 2005;20:633-636.
5. Lee JI, Park H, Jung HY, et al. Prevalence of Barrett's esophagus in an urban Korean population: a multicenter study. J Gastroenterol. 2003;38:23-27.
6. Hongo M. Review article: Barrett's oesophagus and carcinoma in Japan. Aliment Pharmacol Ther. 2004; 20(suppl 8):50-54.
7. Furukawa N, Iwakiri R, Koyama T, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol. 1999;34:441-444.
8. Inamori M, Togawa J, Nagase H, et al. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification. J Gastroenterol Hepatol. 2003;18: 172-176.
9. Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol. 2004;16:495-501.
10. Wong WM, Lam SK, Hui WM, et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese- prevalence and spectrum of the disease. Aliment Pharmacol Ther. 2002;16:2037-2042.
11. Lee SJ, Song CW, Jeen YT, et al. Prevalence of endoscopic reflux esophagitis among Koreans. J Gastroenterol Hepatol. 2001;16:373-376.
12. Shin HR, Won YJ, Jung KW, et al. Nationwide Cancer Incidence in Korea, 1999B2001; First Result Using the National Cancer Incidence Database. Cancer Res Treat. 2005; 37:325-331.
13. Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994;69: 539-547.
14. DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg. 2000;231:303-321.
15. Cameron AJ, Lornboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esopahgus. Gastroenterology. 1995;109:1541-1546.
16. Cortes GR, Villasenor CR. Esophageal cancer. Rev Gastroenterol Mex. 1997;62:149-159.
17. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002;97:1888-1895.
18. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
19. Korean Ministry of Health & Welfare. The Third National Health and Nutrition Examination Survey (KNHANES III) 2005. Korean Ministry of Health & Welfare, Gwacheon-si, Gyeonggi-do, Republic of Korea 2006.
20. Falk GW. Barret's esophagus. Gastroenterology. 2002;122: 1569-1591.
21. Lagergren J. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut. 2005; 54(suppl 1):i1-i5.
22. Parfitt JR, Miladinovic Z, Driman DK. Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada: an epidemiological study from 1964-2002. Can J Gastroenterol. 2006;20:271-276.
23. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510-513.
24. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053.
25. Yoo SS, Lee WH, Ha J, et al. The prevalence of esophageal disorders in the subjects examined for health screening. Korean J Gastroenterol. 2007;50:306-312.
26. Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal highgrade dysplasia or adenocarcinoma. Am J Gastroenterol. 1999; 94:3413-3419.
27. Rudolph RE, Vaughan TL, Storer BE, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med. 2000;132:612-620.
28. Dias Pereira A, Suspiro A, Chaves P. Cancer risk in Barrett's oesophagus. Eur J Gastroenterol Hepatol. 2007;19: 915-918.
29. Weston AP, Krmpotich PT, Cherian R, et al. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol. 1997;92: 407-413.
30. Iftikhar SY, James PD, Steele RJ, et al. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut. 1992;33:1155-1158.
31. Eloubeidi MA, Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol. 1999; 94:937-943.
32. Boyce HW. Barrett esophagus: endoscopic findings and what to biopsy. J Clin Gastroenterol. 2003;36:S6-18; discussion S26-S18.
33. Goda K, Tajiri H, Ikegami M, et al. Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma. Gastrointest Endosc. 2007;65: 36-46.
34. Kara MA, Ennahachi M, Fockens P, et al. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. Gastrointest Endosc. 2006;64:155-166.
35. Rey JF, Inoue H, Guelrud M. Magnification endoscopy with acetic acid for Barrett's esophagus. Endoscopy. 2005;37: 583-586.
36. Sharma P, Bansal A, Mathur S, et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc. 2006;64: 167-175.
37. Chak A, Faulx A, Kinnard M, et al. Identification of Barrett's esophagus in relatives by endoscopic screening. Am J Gastroenterol. 2004;99:2107-2114.
38. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 1998;98:1028-1032.
39. Wong WM, Hui WM, Wong BC. Asia-Pacific consensus on gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004; 19:353-356.
40. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825-1831.
41. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut. 1999;44(suppl 2):S1-S16.
42. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190-200.
43. Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD)-acid reflux and symptom patterns. Aliment Pharmacol Ther. 2003;17:537-545.
44. Quigley EM, DiBaise JK. Non-erosive reflux disease: the real problem in gastro-oesophageal reflux disease. Dig Liver Dis. 2001;33:523-527.
45. Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg. 1999;117:572-580.
46. Neumann CS, Cooper BT. 24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett's oesophagus. Gut. 1994;35:1352-1355.
47. Singh P, Taylor RH, Colin-Jones DG. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol. 1994;89:349-356.
48. Stein HJ, Hoeft S, DeMeester TR. Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg. 1993;105:107-111. (Pubitemid 23033767)
49. Stein HJ, Barlow AP, DeMeester TR, et al. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg. 1992;216:35-43.
50. Veldhuyzen van Zanten SJ, Thomson AB, Barkun AN, et al. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Aliment Pharmacol Ther. 2006; 23:595-599.
51. Ford AC, Forman D, Reynolds PD, et al. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus. Am J Epidemiol. 2005;162:454-460.
52. Banki F, Demeester SR, Mason RJ, et al. Barrett's esophagus in females: a comparative analysis of risk factors in females and males. Am J Gastroenterol. 2005;100:560-567.
53. Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol. 2005;3:1-10.